AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Teva Pharmaceutical Industries Ltd.

Regulatory Filings Aug 8, 2019

7082_rns_2019-08-07_c6cc77bb-2330-4036-b1b1-5dcf01275ebc.htm

Regulatory Filings

Open in Viewer

Opens in native device viewer

������ ������� ������ ������ ���� �� 2019 false

��� ������ ��������� ��"� 2 380
TEVA- PHARMACEUTICAL INDUSTRIES LTD
Corporation no: 520013954 10817
- - -
Israel Securities Authority Tel Aviv Stock Exchange C002 ( Public ) Reported via MAGNA: 07/08/2019
www.isa.gov.il www.tase.co.il Reference: 2019-02-068229 Time of broadcast: 23:16 23:15:47

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on������ ������� ������ ������ ���� �� 2019

Teva_10-Q_Bannerless_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NYSE Date of revision of form structure: 06/08/2019
Address: P.O.B 3190 , Petach Tikva 49131   , Tel: 03-9267267 , 03-9267652 Fax: 03-9267519
E-mail address: [email protected]
Previous names of reporting entity:
Name of the Signatory: Beck Codner Iris Position of Signatory in the reporting corporation: Vice President, Global Corporate Communication Name of Employer Company:
Address: Basel 5 , Petach Tikva 49131 Telephone: 03-9267208 Facsimile: 03-9267851 E-mail: [email protected] 1

Talk to a Data Expert

Have a question? We'll get back to you promptly.